VWM
SGMO

Venturi Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Venturi Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-500
Closed -$510 – 1592
2024
Q4 		$510 Hold
500
– – ﹤0.01% 1921
2024
Q3 		$434 Hold
500
– – ﹤0.01% 1784
2024
Q2 		$180 Hold
500
– – ﹤0.01% 1493
2024
Q1 		$336 Hold
500
– – ﹤0.01% 1362
2023
Q4 		$272 Hold
500
– – ﹤0.01% 1349
2023
Q3 		$300 Hold
500
– – ﹤0.01% 1304
2023
Q2 		$650 Hold
500
– – ﹤0.01% 1055
2023
Q1 		$880 Buy
+500
New +$1.43K ﹤0.01% 1107

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Venturi Wealth Management's SGMO Position: Q1 2025 in Review

Venturi Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 500 shares — an estimated $510 sold.

Venturi Wealth Management first reported a position in SGMO in Q1 2023 and held it in 8 quarters. The position peaked at $880 in Q1 2023. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Venturi Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 500 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $510.
  • Venturi Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2023 and held it in 8 quarters.
  • Venturi Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $880 in Q1 2023.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.